Axsome Therapeutics, Inc. ( AXSM) - Key Metrics
AXSM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.24 | -$1 | -$0.64 | -$0.64 |
| 2026Q1 | $3.73 | -$1.26 | -$0.40 | -$0.41 |
| 2025Q4 | $3.87 | -$0.56 | -$0.37 | -$0.37 |
| 2025Q3 | $3.42 | -$0.94 | $0.02 | $0.02 |
| 2025Q2 | $3.03 | -$0.97 | -$0.66 | -$0.66 |
AXSM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -61.81 |
| 2026Q1 | 0% | -33.54 |
| 2025Q4 | 0% | -81.54 |
| 2025Q3 | 0% | -32.30 |
| 2025Q2 | 0% | -26.90 |
AXSM
Price: $156.32
52 week price:
Earnings Per Share: -3.76 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.9 million
Ebitda: -6.3 millionMarket Capitalization: 9.2 billion